CYTRX CORP
10-Q, EX-27.2, 2000-10-31
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: CYTRX CORP, 10-Q, EX-27.1, 2000-10-31
Next: OFFICE DEPOT INC, 10-Q, 2000-10-31



<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5
<RESTATED>

<S>                             <C>                     <C>
<PERIOD-TYPE>                   3-MOS                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1999             DEC-31-1999
<PERIOD-START>                             JUL-01-1999             JAN-01-1999
<PERIOD-END>                               SEP-30-1999             SEP-30-1999
<CASH>                                       5,357,375                       0
<SECURITIES>                                         0                       0
<RECEIVABLES>                                  236,439                       0
<ALLOWANCES>                                         0                       0
<INVENTORY>                                      6,476                       0
<CURRENT-ASSETS>                             5,697,311                       0
<PP&E>                                       1,540,275                       0
<DEPRECIATION>                               (542,242)                       0
<TOTAL-ASSETS>                               6,766,322                       0
<CURRENT-LIABILITIES>                        1,791,196                       0
<BONDS>                                              0                       0
                                0                       0
                                          0                       0
<COMMON>                                         8,270                       0
<OTHER-SE>                                   4,966,856                       0
<TOTAL-LIABILITY-AND-EQUITY>                 6,766,322                       0
<SALES>                                         75,397                 239,728
<TOTAL-REVENUES>                               350,937               1,169,288
<CGS>                                           51,710                 157,820
<TOTAL-COSTS>                                   51,710                 157,820
<OTHER-EXPENSES>                             5,437,425              12,003,628
<LOSS-PROVISION>                                     0                       0
<INTEREST-EXPENSE>                                   0                       0
<INCOME-PRETAX>                            (5,138,198)            (10,992,160)
<INCOME-TAX>                                         0                       0
<INCOME-CONTINUING>                        (5,138,198)            (10,992,160)
<DISCONTINUED>                                 252,385                 165,184
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                               (4,885,813)            (10,826,976)
<EPS-BASIC>                                      (.64)                  (1.42)
<EPS-DILUTED>                                    (.64)                  (1.42)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission